Search Results - "Serrano López, Juana"

Editorial: Implications of immune landscape in tumor microenvironment by Chutipongtanate, Somchai, Ponnazhagan, Selvarangan, Serrano-López, Juana

Get full text

Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population‐based study by Sánchez‐Vizcaíno, Fernando, Tamayo, Carmen, Ramos, Fernando, Láinez‐González, Daniel, Serrano‐López, Juana, Barba, Raquel, Martin, Maria Dolores, Llamas, Pilar, Alonso‐Dominguez, Juan Manuel

“…Summary Until now, the role that seasonal factors play in the aetiology of acute myeloid leukaemia (AML) has been unclear. Demonstration of seasonality in AML…”
Get full text

Inflammaging, an Imbalanced Immune Response That Needs to Be Restored for Cancer Prevention and Treatment in the Elderly by Serrano-López, Juana, Martín-Antonio, Beatriz

“…Nowadays, new advances in society and health have brought an increased life expectancy. However, at the same time, aging comes with complications that impact…”
Get full text

Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure by Lainez-González, Daniel, Serrano-López, Juana, Alonso-Domínguez, Juan Manuel

“…A better understanding of how signaling pathways govern cell fate is fundamental to advances in cancer development and treatment. The initialization of…”
Get full text

PB1827: TWO‐LEVEL INHIBITION OF HEDGEHOG SIGNALLING PATHWAY TO EXIT QUIESCENT STATE IN ACUTE MYELOID LEUKAEMIA by Láinez‐González, Daniel, Justo‐Bermejo, Francisco Javier, Serrano‐López, Juana, Alonso‐Dominguez, Juan Manuel

Get full text

PB1820: THE EFFECT OF CONVENTIONAL CHEMOTHERAPY AFTER EXITING QUIESCENT STATE IN ACUTE MYELOID LEUKAEMIA by Láinez‐González, Daniel, Alonso‐Aguado, Ana Belén, Serrano‐López, Juana, Alonso‐Dominguez, Juan Manuel

Get full text

A Multidisciplinary Journey towards Bone Tissue Engineering by Pedrero, Sara G, Llamas-Sillero, Pilar, Serrano-López, Juana

“…Millions of patients suffer yearly from bone fractures and disorders such as osteoporosis or cancer, which constitute the most common causes of severe…”
Get full text

Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia by Serrano-López, Juana, Sanchez-Garcia, Joaquin, Serrano, Josefina, Alvarez-Rivas, Miguel A., Garcia-Castellano, Jose M., Roman-Gomez, Jose, Rosa, Olga de la, Herrera-Arroyo, Concepcion, Torres-Gomez, Antonio

“…BACKGROUND: Dendritic cell (DC)‐based immunotherapeutic protocols are being developed to treat acute myeloid leukemia (AML). So far, DCs for clinical use are…”
Get full text

Understanding the Notch Signaling Pathway in Acute Myeloid Leukemia Stem Cells: From Hematopoiesis to Neoplasia by Láinez-González, Daniel, Serrano-López, Juana, Alonso-Dominguez, Juan Manuel

“…The Notch signaling pathway is fundamental to early fetal development, but its role in acute myeloid leukemia is still unclear. It is important to elucidate…”
Get full text

Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients by Sanchez-Garcia, Joaquin, Serrano-López, Juana, García-Sanchez, Valle, Alvarez-Rivas, Miguel A, Jimenez-Moreno, Rosario, Pérez-Seoane, Carlos, Herrera-Arroyo, Concepcion, Serrano, Josefina, De Dios, Juan F, Torres-Gomez, Antonio

“…Background and Aim:  In human blood, two main subsets of antigen‐presenting‐cells (APCs) have been described: plasmocytoid dendritic cells (pDC) and myeloid…”
Get full text

Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model by Moreno, Víctor M., Álvarez, Elena, Izquierdo‐Barba, Isabel, Baeza, Alejandro, Serrano‐López, Juana, Vallet‐Regí, María

“…One of the major concerns in the application of nanocarriers in oncology is their scarce penetration capacity in tumoral tissues. Living organisms (cells and…”
Get full text

Editorial: Driving extracellular vesicles toward applications in precision medicine by Chutipongtanate, Somchai, Pattanapanyasat, Kovit, Meller, Jarek, Serrano López, Juana

Get full text

Identifying prognostic gene panels in acute myeloid leukemia by Sanchez-Garcia, Joaquin, Serrano, Josefina, Prados de La Torre, Esther, Serrano-López, Juana, Aparicio-Perez, Clara, Barragán, E, Montesinos, Pau

“…Acute myeloid leukemia (AML) is a heterogeneous disease currently including 12 entities defined by genetic findings with remarkable differences in prognosis…”
Get more information

Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia by Serrano-Lopez, J., Serrano, J., Figueroa, V., Torres-Gomez, A., Tabares, S., Casano, J., Fernandez-Escalada, N., Sanchez-Garcia, J.

“…Survivin is over-expressed in most hematologic malignancies but the prognostic significance of the subcompartmental distribution of wild-type or splicing…”
Get full text

Large-scale production of superparamagnetic iron oxide nanoparticles by flame spray pyrolysis: In vitro biological evaluation for biomedical applications by Estévez, Manuel, Cicuéndez, Mónica, Crespo, Julián, Serrano-López, Juana, Colilla, Montserrat, Fernández-Acevedo, Claudio, Oroz-Mateo, Tamara, Rada-Leza, Amaia, González, Blanca, Izquierdo-Barba, Isabel, Vallet-Regí, María

“…[Display omitted] Despite the large number of synthesis methodologies described for superparamagnetic iron oxide nanoparticles (SPIONs), the search for their…”
Get full text

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells by Rio-Vilariño, Anxo, Cenigaonandia-Campillo, Aiora, García-Bautista, Ana, Mateos-Gómez, Pedro A., Schlaepfer, Marina I., del Puerto-Nevado, Laura, Aguilera, Oscar, García-García, Laura, Galeano, Carlos, de Miguel, Irene, Serrano-López, Juana, Baños, Natalia, Fernández-Aceñero, María Jesús, Lacal, Juan Carlos, Medico, Enzo, García-Foncillas, Jesús, Cebrián, Arancha

“…Background Primary resistance to anti-EGFR therapies affects 40% of metastatic colorectal cancer patients harbouring wild-type RAS/RAF . YAP1 activation is…”
Get full text

High-throughput RNA sequencing transcriptome analysis of ABC-DLBCL reveals several tumor evasion strategies by Serrano López, Juana, Jiménez-Jiménez, Carla, Chutipongtanate, Somchai, Serrano, Josefina, Rodríguez-Moreno, Marta, Jiménez, Álvaro, Jiménez, Yesenia, G. Pedrero, Sara, Laínez, Daniel, Alonso-Domínguez, Juan Manuel, Llamas Sillero, Pilar, Piris, Miguel Ángel, Sánchez-García, Joaquín

“…Activated B-cell (ABC) lymphoma, a distinct molecular entity within diffuse large B-cell lymphoma (DLBCL), remains highly incurable, showing a worse response…”
Get full text

Development and validation of a predictive model of in-hospital mortality in COVID-19 patients by Velasco-Rodríguez, Diego, Alonso-Dominguez, Juan-Manuel, Vidal Laso, Rosa, Lainez-González, Daniel, García-Raso, Aránzazu, Martín-Herrero, Sara, Herrero, Antonio, Martínez Alfonzo, Inés, Serrano-López, Juana, Jiménez-Barral, Elena, Nistal, Sara, Pérez Márquez, Manuel, Askari, Elham, Castillo Álvarez, Jorge, Núñez, Antonio, Jiménez Rodríguez, Ángel, Heili-Frades, Sarah, Pérez-Calvo, César, Górgolas, Miguel, Barba, Raquel, Llamas-Sillero, Pilar

“…We retrospectively evaluated 2879 hospitalized COVID-19 patients from four hospitals to evaluate the ability of demographic data, medical history, and…”
Get full text

Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD by Serrano-López, Juana, Fernández, José Luis, Lumbreras, Eva, Serrano, Josefina, Martínez-Losada, Carmen, Martín, Carmen, Hernández-Rivas, Jesús M., Sánchez-García, Joaquín

Get full text

Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse? by Aparicio-Pérez, Clara, Prados de la Torre, Esther, Sanchez-Garcia, Joaquin, Martín-Calvo, Carmen, Martínez-Losada, Carmen, Casaño-Sanchez, Javier, Serrano-López, Juana, Serrano, Josefina

“…Acute myeloid leukemia (AML) is a heterogeneous disease classified into three risk categories (favorable, intermediate and adverse) with significant…”
Get full text